These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 23466826)
1. Common drug interactions following traumatic brain injury. Levine JM J Head Trauma Rehabil; 2013; 28(2):151-4. PubMed ID: 23466826 [No Abstract] [Full Text] [Related]
2. [Antipsychotics: side effects and drug interaction]. Yoshimasu K; Kuroki T Ryoikibetsu Shokogun Shirizu; 2003; (38):172-5. PubMed ID: 12876958 [No Abstract] [Full Text] [Related]
3. Severe INR elevation related to duloxetine use: a case report. Gimenez C; Guce G; Lingisetty C; Bernhardt L Psychosomatics; 2011; 52(6):583-5. PubMed ID: 22054632 [No Abstract] [Full Text] [Related]
4. Warfarin: pharmacological profile and drug interactions with antidepressants. Teles JS; Fukuda EY; Feder D Einstein (Sao Paulo); 2012; 10(1):110-5. PubMed ID: 23045839 [TBL] [Abstract][Full Text] [Related]
5. Decreased INR response secondary to warfarin-flucloxacillin interaction. Garg A; Mohammed M Ann Pharmacother; 2009 Jul; 43(7):1374-5. PubMed ID: 19584391 [No Abstract] [Full Text] [Related]
6. Sense and non-sense of polypharmacy: increasing efficacy, decreasing compliance? Boyer P Eur Psychiatry; 2003 Dec; 18 Suppl 2():54s-61s. PubMed ID: 23570197 [No Abstract] [Full Text] [Related]
7. Drug-drug interactions between warfarin and psychotropics: updated review of the literature. Nadkarni A; Oldham MA; Howard M; Berenbaum I Pharmacotherapy; 2012 Oct; 32(10):932-42. PubMed ID: 23033232 [TBL] [Abstract][Full Text] [Related]
8. Rational polypharmacy in the bipolar affective disorders. Post RM; Ketter TA; Pazzaglia PJ; Denicoff K; George MS; Callahan A; Leverich G; Frye M Epilepsy Res Suppl; 1996; 11():153-80. PubMed ID: 9294735 [TBL] [Abstract][Full Text] [Related]
9. Treating depression in schizophrenia. Lund BC; Perry PJ; Miller DD Am J Psychiatry; 2001 Sep; 158(9):1528-9. PubMed ID: 11532750 [No Abstract] [Full Text] [Related]
10. An evaluation of risperidone drug interactions. DeVane CL; Nemeroff CB J Clin Psychopharmacol; 2001 Aug; 21(4):408-16. PubMed ID: 11476125 [TBL] [Abstract][Full Text] [Related]
11. Serious erythromycin interactions caused by inhibition of drug metabolism in the liver. Wynn RL Gen Dent; 1996; 44(6):486-8, 490. PubMed ID: 9515389 [No Abstract] [Full Text] [Related]
12. Terbinafine and potential drug interactions. Kaplan DL J Am Acad Dermatol; 2000 Nov; 43(5 Pt 1):882-4. PubMed ID: 11050604 [No Abstract] [Full Text] [Related]
13. Catatonia-like events after valproic acid with risperidone and sertraline. Lauterbach EC Neuropsychiatry Neuropsychol Behav Neurol; 1998 Jul; 11(3):157-63. PubMed ID: 9742515 [TBL] [Abstract][Full Text] [Related]
14. [Bipolar depression: a review of current therapeutic strategies]. Thuile J; Even C; Guelfi JD Encephale; 2006 Oct; 32(5 Pt 1):767-74. PubMed ID: 17099601 [TBL] [Abstract][Full Text] [Related]
15. Relevance of new psychotropic drugs for the neurologist. Hensiek AE; Trimble MR J Neurol Neurosurg Psychiatry; 2002 Mar; 72(3):281-5. PubMed ID: 11861679 [No Abstract] [Full Text] [Related]
19. The effect of drug interactions on bleeding risk associated with warfarin therapy in hospitalized patients. Hauta-Aho M; Tirkkonen T; Vahlberg T; Laine K Ann Med; 2009; 41(8):619-28. PubMed ID: 19711211 [TBL] [Abstract][Full Text] [Related]